Salud financiera de hoja de balance de Anhui Anke Biotechnology (Group)
Salud financiera controles de criterios 6/6
Anhui Anke Biotechnology (Group) has a total shareholder equity of CN¥4.1B and total debt of CN¥5.0M, which brings its debt-to-equity ratio to 0.1%. Its total assets and total liabilities are CN¥5.0B and CN¥858.6M respectively. Anhui Anke Biotechnology (Group)'s EBIT is CN¥817.7M making its interest coverage ratio -46.9. It has cash and short-term investments of CN¥1.3B.
Información clave
0.1%
Ratio deuda-patrimonio
CN¥5.00m
Deuda
| Ratio de cobertura de intereses | -46.9x |
| Efectivo | CN¥1.27b |
| Patrimonio | CN¥4.13b |
| Total pasivo | CN¥858.57m |
| Activos totales | CN¥4.99b |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Anhui Anke Biotechnology (Group) Co., Ltd.'s (SZSE:300009) Share Price Is Matching Sentiment Around Its Earnings
Sep 25
Anhui Anke Biotechnology (Group) (SZSE:300009) Will Pay A Dividend Of CN¥0.25
May 23Earnings Working Against Anhui Anke Biotechnology (Group) Co., Ltd.'s (SZSE:300009) Share Price
Mar 01Análisis de la situación financiera
Pasivos a corto plazo: 300009's short term assets (CN¥2.2B) exceed its short term liabilities (CN¥699.8M).
Pasivo a largo plazo: 300009's short term assets (CN¥2.2B) exceed its long term liabilities (CN¥158.8M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 300009 has more cash than its total debt.
Reducción de la deuda: 300009's debt to equity ratio has reduced from 1.7% to 0.1% over the past 5 years.
Cobertura de la deuda: 300009's debt is well covered by operating cash flow (14960.9%).
Cobertura de intereses: 300009 earns more interest than it pays, so coverage of interest payments is not a concern.